Home > Insider Trading > Filing (0000899243-22-035521)

Filing Details

Accession Number:: 0000899243-22-035521
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-10 16:30:27
Reporting Period:: 2022-11-08

Accepted Time:: 2022-11-10 16:30:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610676	Anne Mary Heino	C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-11-08	2,000	$55.94	683,683	No	4	S	Direct
Common Stock	Disposition	2022-11-08	4,750	$56.66	678,933	No	4	S	Direct
Common Stock	Disposition	2022-11-08	4,884	$57.86	674,049	No	4	S	Direct
Common Stock	Disposition	2022-11-08	1,516	$58.58	672,533	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.36 to $56.33, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH"), any security holder of LNTH, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.36 to $57.31, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.36 to $58.35, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.38 to $58.97, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.